XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Jun. 24, 2023
Jun. 25, 2022
Operating activities:    
Net earnings $ 48,485 $ 29,925
Adjustments to reconcile net earnings to net cash provided by operating activities    
Depreciation of fixed assets 41,319 36,292
Amortization of intangibles and deferred costs 5,065 1,775
(Gain) loss from disposals of property & equipment (255) 50
Share-based compensation 3,935 3,484
Deferred income taxes (937) (227)
(Gain) loss on marketable securities (105) 412
Other (237) (212)
Changes in assets and liabilities, net of effects from purchase of companies    
Increase in accounts receivable (7,680) (78,058)
Decrease (increase) in inventories 4,875 (42,784)
Decrease (increase) in prepaid expenses 8,487 (102)
Increase in accounts payable and accrued liabilities 2,992 19,798
Net cash provided by (used in) operating activities 105,944 (29,647)
Investing activities:    
Payments for purchases of companies, net of cash acquired 0 (221,301)
Purchases of property, plant and equipment (76,472) (64,231)
Proceeds from redemption and sales of marketable securities 5,300 11,526
Proceeds from disposal of property and equipment 774 1,147
Net cash (used in) investing activities (70,398) (272,859)
Financing activities:    
Proceeds from issuance of stock 6,289 12,168
Borrowings under credit facility 102,000 125,000
Repayment of borrowings under credit facility (74,000) 0
Payments for debt issuance costs 0 (225)
Payments on finance lease obligations (150) (150)
Payment of cash dividend (40,389) (36,299)
Net cash (used in) provided by financing activities (6,250) 100,494
Effect of exchange rates on cash and cash equivalents 1,166 103
Net increase (decrease) in cash and cash equivalents 30,462 (201,909)
Cash and cash equivalents at beginning of period 35,181 283,192
Cash and cash equivalents at end of period $ 65,643 $ 81,283